Peg-L-Asparaginase (K-H)


Combined with:

Cytarabine
Methotrexate
Vincristine Sulfate

Indications and Reactions:

Role Indications Reactions
Secondary
Precursor B-lymphoblastic Lymphoma 42.9%
Lymphocytic Leukaemia 28.6%
Drug Therapy 14.3%
Precursor T-lymphoblastic Lymphoma/leukaemia 14.3%
Vomiting 22.2%
Pyrexia 10.0%
Thrombocytopenia 6.7%
White Blood Cell Count Decreased 6.7%
Pneumoperitoneum 4.4%
Respiratory Arrest 4.4%
Septic Shock 4.4%
Staphylococcal Infection 4.4%
Tachycardia 4.4%
Unresponsive To Stimuli 4.4%
Febrile Neutropenia 3.3%
Jaundice 3.3%
Respiratory Failure 3.3%
Weight Decreased 3.3%
Weight Increased 3.3%
Muscular Weakness 2.2%
Nausea 2.2%
No Therapeutic Response 2.2%
Pseudomonal Sepsis 2.2%
Respiratory Disorder 2.2%

Drug Data